枕骨大孔脑膜瘤的遗传特征与突变谱:一项多中心研究
该多中心研究对来自三家国际机构的62例枕骨大孔脑膜瘤行靶向二代测序,覆盖AKT1、KLF4、NF2、POLR2A、PIK3CA、SMO、TERT启动子及TRAF7基因。58例(93.5%)检出具有临床意义的驱动突变,TRAF7突变26例(41.9%)最常见,其次为AKT1E17K突变19例(30.6%);TRAF7与AKT1E17K突变均与肿瘤位于脑干前侧方显著相关(p=0.0078)。
要点
- 58例(93.5%)检出临床意义驱动突变,TRAF7突变26例(41.9%)最常见。
- AKT1E17K突变19例(30.6%),与TRAF7突变均与脑干前侧方位置相关(p=0.0078)。
- NF2突变11例(17.7%)与肿瘤位于后侧相关,瘤内钙化在NF2突变者较AKT1突变者更常见(p=0.047)。
核心结论
- 枕骨大孔脑膜瘤中驱动突变检出率高,特定遗传改变与肿瘤位置、体积、钙化、组织学及诊断时性别相关,可能对未来个体化治疗策略有启示。
研究设计与样本
- 对来自三家国际机构的62例枕骨大孔脑膜瘤行靶向二代测序,覆盖AKT1、KLF4、NF2、POLR2A、PIK3CA、SMO、TERT启动子及TRAF7基因。
- 排除放射性脑膜瘤或2型神经纤维瘤病(NF2)患者,回顾性收集并评估年龄、性别、影像学特征及肿瘤位置等患者与肿瘤特征。
主要发现
- 队列含46例女性与16例男性患者,58例(93.5%)检出具有临床意义的驱动突变。
- TRAF7突变26例(41.9%)最常见,其次为AKT1E17K突变19例(30.6%),两者均与肿瘤位于脑干前侧方显著相关(p=0.0078)。
- NF2突变11例(17.7%),与后侧肿瘤位置相关,与TRAF7及AKT1E17K突变肿瘤相反。
- 其他突变包括POLR2A突变8例(12.9%;6例POLR2AQ403K、2例POLR2AH439_L440del)、KLF4K409Q突变7例(11.3%)、PIK3CA突变4例(6.5%;2例PIK3CAH1047R、2例PIK3CAE545K)。
- POLR2A与KLF4突变仅见于女性患者,与特定肿瘤位置无显著关联;所有携带AKT1E17K与POLR2A突变的肿瘤均呈脑膜上皮型组织学;10例肿瘤有瘤内钙化,NF2突变者较AKT1突变者更常见(p=0.047)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Foramen magnum (FM) meningiomas pose significant surgical challenges and have high morbidity and mortality rates. This study aimed to investigate the distribution of clinically actionable mutations in FM meningiomas and identify clinical characteristics associated with specific mutational profiles. METHODS: The authors conducted targeted next-generation sequencing of 62 FM meningiomas from three international institutions, covering all relevant meningioma genes (AKT1, KLF4, NF2, POLR2A, PIK3CA, SMO, TERT promoter, and TRAF7). Patients with a radiation-induced meningioma or neurofibromatosis type 2 (NF2) were excluded from the study. Additionally, patient and tumor characteristics, including age, sex, radiological features, and tumor location, were retrospectively collected and evaluated. RESULTS: The study cohort consisted of 46 female and 16 male patients. Clinically significant driver mutations were detected in 58 patients (93.5%). The most commonly observed alteration was TRAF7 mutations (26, 41.9%), followed by AKT1E17K mutations (19, 30.6%). Both mutations were significantly associated with an anterolateral tumor location relative to the brainstem (p = 0.0078). NF2 mutations were present in 11 cases (17.7%) and were associated with posterior tumor location, in contrast to tumors with TRAF7 and AKT1E17K mutations. Other common mutations in FM meningiomas included POLR2A mutations (8, 12.9%; 6 POLR2AQ403K and 2 POLR2AH439_L440del), KLF4K409Q mutations (7, 11.3%), and PIK3CA mutations (4, 6.5%; 2 PIK3CAH1047R and 2 PIK3CAE545K). POLR2A and KLF4 mutations exclusively occurred in female patients and showed no significant association with specific tumor locations. All tumors harboring AKT1E17K and POLR2A mutations displayed meningothelial histology. Ten tumors exhibited intratumoral calcification, which was significantly more frequent in NF2-mutant compared with AKT1-mutant FM meningiomas (p = 0.047). CONCLUSIONS: These findings provide important insights into the molecular genetics and clinicopathological characteristics of FM meningiomas. The identification of specific genetic alterations associated with tumor location, volume, calcification, histology, and sex at diagnosis may have implications for personalized treatment strategies in the future.
引用
- Hua L, Alkhatib M, Fujio S, et al. Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study. J Neurosurg. 2024. PMID: 38277657. doi:10.3171/2023.11.JNS231936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。